checkAd

     163  0 Kommentare Chimerix Announces Pricing of Public Offering of Common Stock - Seite 3

    CONTACT:
    Investor Relations:
    Michelle LaSpaluto
    919 972-7115
    ir@chimerix.com

    Will O’Connor
    Stern Investor Relations
    212-362-1200
    will@sternir.com

    Media:
    David Schull
    Russo Partners
    858-717-2310
    David.Schull@russopartnersllc.com


     

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Chimerix Announces Pricing of Public Offering of Common Stock - Seite 3 DURHAM, N.C., Jan. 20, 2021 (GLOBE NEWSWIRE) - Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced today the pricing of its …